Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)
Clinical trial NCT05664893 · WITHDRAWN
Trial details
- NCT number
- NCT05664893
- Sponsor
- Centre Antoine Lacassagne
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-26
- Primary completion
- 2026-03-26
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.